SEC Form D · filed March 13, 2018
ADIAL PHARMACEUTICALS, INC
Location
CHARLOTTESVILLE, VA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
James W. Newman, Jr · Charlottesville, VADirectorRobertson H. Gilliland · Charlottesville, VADirectorBankole A. Johnson · Charlottesville, VADirectorKevin W. Schuyler, Cfa · Charlottesville, VADirectorWilliam B. Stilley, Iii · Charlottesville, VAExec · DirectorJoseph M. Truluck · Charlottesville, VAExecJames K. Anderson · Charlottesville, VADirectorTony W. Goodman · Charlottesville, VADirectorW. C. Mccollum · Los Angeles, CAExecPeter Feld · New York, NYDirectorJason Bergsman · Playa Vista, CADirectorSever Totia · New York, NYDirectorJesse S. Jacobs · Playa Vista, CADirectorMike Kerns · Playa Vista, CADirectorKweli Washington · New York, NYDirectorGina Mondo · Norwich, CTExec · DirectorUrsula Newman · London, United KingdomDirectorThomas Scriven · Golden, CODirectorMatthew Davis · Purcellville, VADirectorFred Ausubel · Allston, MAExecIsaac Stoner · Allston, MAExec · DirectorCory Brown · Nashville, TNDirectorLauren Smith · Nashville, TNDirectorKiran N. Bhatraju · Shepherdstown, WVDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗